The Sydney Morning Herald logo

Proteomics International Laboratories

Advertisement
Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer.

Proteomics locks in US patent for throat cancer test

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.

  • Doug Bright

Latest

The Centers for Medicare & Medicaid Services, otherwise known as Medicare, which is headquartered in Baltimore in the United States.

US Medicare sets cracking unit price for Proteomics diabetes test

Proteomics has scored a major US win, with Medicare setting a US$390.75 reimbursement price for its predictive kidney disease blood test, clearing the path for nationwide clinical uptake.

  • James Pearson
The results of Proteomics OxiDx blood testing trials are being presented today in Sydney at the Australian Physiological Society (AuPS) Annual Scientific Meeting.

Proteomics equine blood test gives racing edge

A study on Proteomics’ new “OxiDx” blood test shows horses without oxidative stress are far more likely to win or place, underscoring demand for evidence‑based performance diagnostics.

  • Bill McConnell
Proteomics International Laboratories has achieved certification for its Perth lab, which will provide world-class test results for precision medicine.

Proteomics scores approval for Perth diagnostics lab

Proteomics International Laboratories has achieved pivotal certification for its industrial-scale WA lab, supporting the national roll-out of its precision blood tests.

  • Andrew Todd
: Trials of Proteomics International’s PromarkerEso blood test have delivered a near-perfect score for the detection of throat cancer across all stages of the disease.

Proteomics makes blood test breakthrough for deadly throat cancer

Proteomics International’s PromarkerEso blood test can accurately detect early-stage throat cancer, offering hope of survival beyond the average one-year prognosis.

  • James Pearson
Proteomics International Laboratories’ innovative OxiDx muscle stress test could soon be used to monitor muscle damage in thoroughbred horses and elite athletes.

Proteomics streaks ahead with simple test for injured racehorses

Proteomics International aims to deliver a world-first blood test this year to detect muscle damage in racehorses, revolutionising the way injuries are monitored.

  • Belinda Hickman
Advertisement
Proteomics International’s PromarkerD diabetes-related blood test has just been assigned an American Medical Association billing code, required for doctors in the United State to order the test and for facilities to bill for its use.

Proteomics diabetes test gets important US health insurance nod

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes blood test across the US, ahead of its global commercialisation.

  • Belinda Hickman
Proteomics research scientist Martin Mead adjusts a mass spectrometer column used for its proteomics diagnostics research in the company’s Perth laboratory.

$6M boost to drive industrial-scale Proteomics facility in WA

Proteomics International will expand its Perth facility using $6M in funding to develop a platform to run industrial-scale medical and agricultural diagnostics.

  • Belinda Hickman
Proteomics International has patented PromarkerEndo, its breakthrough early diagnostic test for endometriosis, in Japan.

Milestone first patent for Proteomics simple endometriosis test

Proteomics International has achieved the company’s first patent globally in Japan for its breakthrough PromarkerEndo diagnostic test for early endometriosis.

  • Belinda Hickman
Proteomics International Laboratories has officially launched the US rollout of its PromarkerD kidney diagnostic test at a conference in Chicago attended by the world’s largest gathering of diabetes experts.

Proteomics flags US rollout of kidney test at global diabetes summit

Proteomics International has launched its PromarkerD diagnostic test at a major diabetes event, offering early diabetic kidney disease detection to millions of Americans

  • James Pearson